Acute hepatitis C: current status and remaining challenges

Area of Science:

• Hepatology
• Infectious Diseases
• Virology

Background:

• Acute hepatitis C virus (HCV) infection is a critical stage with variable outcomes, progressing to spontaneous resolution or chronic disease.
• Diagnosis is challenging due to frequent asymptomatic presentation, complicating early intervention.
• Lack of established treatment guidelines forces clinicians to make difficult therapeutic decisions regarding treatment initiation and regimen selection.

Purpose of the Study:

• To review the epidemiology, risk factors, and transmission routes of acute HCV infection.
• To examine current treatment practices for acute hepatitis C.
• To identify unresolved issues and the need for further research to establish standardized treatment guidelines.

Main Methods:

• Review of published clinical studies and epidemiological data on acute hepatitis C.
• Analysis of current treatment approaches, including pegylated interferon alfa monotherapy.
• Discussion of unresolved clinical questions and areas requiring further investigation.

Main Results:

• Acute hepatitis C is often asymptomatic, hindering timely diagnosis and treatment.
• Pegylated interferon alfa monotherapy is the most common treatment, but the role of ribavirin is not yet defined.
• Significant challenges exist in managing acute HCV due to a lack of standardized guidelines.

Conclusions:

• Standardized treatment guidelines are urgently needed for the effective management of acute hepatitis C.
• Further clinical studies are essential to address current uncertainties in treatment strategies.
• Improved diagnostic approaches may facilitate earlier detection and intervention for acute HCV infection.